Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Oxidative Cleavage. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1010944B reveals a novel oxidative cleavage route for glyoxylylspermidine. This report analyzes cost reduction in API manufacturing and supply chain reliability for this critical pharmaceutical intermediate.
Patent CN1228342C details a novel route for Gemcitabine using 1,6-dehydro-beta-D-glucose, offering improved stereoselectivity and cost reduction in API manufacturing.